Evidence map›Paper›PMID 33816628›Full record

ArticleBioMed research international2021

Fabrication of Carbamazepine Cocrystals: Characterization,

Muhammad Wasim, Abdul Mannan, Muhammad Hassham Hassan Bin Asad, Muhammad Imran Amirzada, Muhammad Shafique, Izhar Hussain

Abstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad WasimDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus Abbottabad 22060, Pakistan.
Abdul MannanDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus Abbottabad 22060, Pakistan.
Muhammad Hassham Hassan Bin AsadDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus Abbottabad 22060, Pakistan.ORCID https://orcid.org/0000-0002-2739-9416
Muhammad Imran AmirzadaDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus Abbottabad 22060, Pakistan.
Muhammad ShafiqueDepartment of Pharmaceutical Science, College of Pharmacy-Boys, Shaqra University, Al-Dawadmi Campus 17441, Shaqra 11911, Saudi Arabia.
Izhar HussainDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus Abbottabad 22060, Pakistan.ORCID https://orcid.org/0000-0002-2473-5197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbamazepine (CBZ) is an antiepileptic drug having low bioavailability due to its hydrophobic nature. In the current study, efforts are made to investigate the effect of dicarboxylic acid coformer spacer groups (aliphatic chain length) on physicochemical properties, relative humidity (RH) stability, and oral bioavailability of CBZ cocrystals. Slurry crystallization technique was employed for the preparation of CBZ cocrystals with the following coformers: adipic (AA), glutaric (GA), succinic (SA), and malonic acid (MA). Powder X-ray diffractometry and Fourier-transform infrared spectroscopy confirmed cocrystal preparation. Physicochemical properties, RH stability, and oral bioavailability of cocrystals were investigated. Among the prepared cocrystals, CBZ-GA showed maximum solubility as well as improved dissolution profile (CBZ-GA > CBZ-MA > CBZ-AA > pure CBZ > CBZ-SA) in ethanol. Maximum RH stability was shown by CBZ-AA, CBZ-SA, and CBZ-MA.

Indexed as

CarbamazepineAnimalsBiological AvailabilityCalorimetry, Differential ScanningCrystallizationDrug Evaluation, PreclinicalDrug StabilityRabbitsCarbamazepine

Identifiers

PMID33816628
PMCPMC7987437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.